TY - CHAP M1 - Book, Section TI - Inoue-Balloon Mitral Valvuloplasty A1 - Hung, Jui-Sung A1 - Lau, Kean-Wah A1 - Yeung, Alan C. A2 - Samady, Habib A2 - Fearon, William F. A2 - Yeung, Alan C. A2 - King III, Spencer B. PY - 2017 T2 - Interventional Cardiology, 2e AB - The introduction of percutaneous balloon mitral valvuloplasty (BMV) by Inoue et al1 in 1982 has opened a new dimension in the treatment of patients with mitral stenosis. The body of data accrued to date has clearly established this invasive, nonsurgical procedure as the treatment of choice in symptomatic patients with moderate to severe mitral stenosis (mitral valve area <1.5 cm2) and favorable valve morphology (noncalcified, pliable valve with minimal subvalvular disease and no or mild mitral regurgitation).2-5 The presence of either severe (grade ≥3) angiographic mitral regurgitation or left atrial thrombus is considered to be a contraindication for BMV. However, several controversial issues in the use of this procedure exist, because the selection of patients for BMV in clinical practice continues to be a complex decision involving consideration of multiple variables, including clinical profile, operator skill, valve morphology, and severity of associated mitral regurgitation. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesscardiology.mhmedical.com/content.aspx?aid=1146603303 ER -